Career history of Lars Henrik Høie
Former positions of Lars Henrik Høie
| Companies | Position | Start | End |
|---|---|---|---|
Nutri Pharma ASA
 Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Nutri Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases such as obesity, elevated cholesterol levels and diabetes. The firm's products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment). It develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The company was founded in 1993 and is headquartered in Oslo, Norway | Chief Tech/Sci/R&D Officer | 01/01/1993 | - |
| Founder | 01/01/1993 | - | |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Director/Board Member | 25/07/2011 | - |
| Chairman | 26/07/2011 | - |
Training of Lars Henrik Høie
| University of Oslo | Doctorate Degree |
Statistics
International
| Norway | 4 |
Operational
| Director/Board Member | 1 |
| Chairman | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
Nutri Pharma ASA
Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Nutri Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases such as obesity, elevated cholesterol levels and diabetes. The firm's products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment). It develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The company was founded in 1993 and is headquartered in Oslo, Norway | Commercial Services |
- Stock Market
- Insiders
- Lars Henrik Høie
- Experience
